CymitQuimica logo

CAS 65906-75-4

:

ethyl 4-butoxy-5-fluoro-2,6-dioxohexahydropyrimidine-5-carboxylate

Description:
Ethyl 4-butoxy-5-fluoro-2,6-dioxohexahydropyrimidine-5-carboxylate, with the CAS number 65906-75-4, is a synthetic organic compound that belongs to the class of pyrimidine derivatives. This compound features a pyrimidine ring, which is a six-membered aromatic heterocycle containing nitrogen atoms. The presence of a butoxy group and a fluoro substituent contributes to its unique chemical properties, potentially influencing its solubility, reactivity, and biological activity. The dioxo functional groups indicate the presence of two carbonyl (C=O) groups, which can participate in various chemical reactions, including nucleophilic attacks and condensation reactions. Ethyl esters, such as the carboxylate moiety in this compound, are often characterized by their volatility and ability to undergo hydrolysis. The specific arrangement of substituents on the pyrimidine ring can affect the compound's pharmacological properties, making it of interest in medicinal chemistry. Overall, this compound's structure suggests potential applications in pharmaceuticals or agrochemicals, although detailed studies would be necessary to elucidate its specific properties and uses.
Formula:C11H17FN2O5
InChI:InChI=1/C11H17FN2O5/c1-3-5-6-19-8-11(12,9(16)18-4-2)7(15)13-10(17)14-8/h8H,3-6H2,1-2H3,(H2,13,14,15,17)
SMILES:CCCCOC1C(C(=NC(=N1)O)O)(C(=O)OCC)F
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
  • Ethyl 4-butoxy-5-fluoro-2,6-dioxohexahydropyrimidine-5-carboxylate
    Biosynth
    + Info

    Ethyl 4-butoxy-5-fluoro-2,6-dioxohexahydropyrimidine-5-carboxylate

    Controlled Product
    CAS:
    <p>Ethyl 4-butoxy-5-fluoro-2,6-dioxohexahydropyrimidine-5-carboxylate is a drug that has been used in clinical studies for the treatment of primary brain tumors. It has shown clinical response rates of up to 87%, with the most favourable response observed in patients with low tumor grade and well differentiated histology. The drug is administered orally and penetrates tissues, including the central nervous system. Ethyl 4-butoxy-5-fluoro-2,6-dioxohexahydropyrimidine-5 carboxylate has been found to be toxic to ameloblasts and cancer cells in vitro. Tumor regression was observed in animals treated with ethyl 4 butoxy 5 fluoro 2 6 dioxohexahydropyrimidine 5 carboxylate, which led to decreased symptoms such as weight loss and cachexia.</p>
    Formula:C11H17FN2O5
    Purity:Min. 95%
    Molecular weight:276.26 g/mol

    Ref: 3D-FE98042

    ne
    To inquire